|
Antitumor B-carboline derivatives |
|
Principal Investigator: A. JOSSANG and G. UZAN
|
TECHNICAL DESCRIPTION
This invention describes, in immunodeficient animal model, the use of a novel combination of compounds displaying antitumoral activities against xenografted human tumor by oral administration. The said combination includes a Peganum harmala derivatives with 30 % of therapeutic dose of a DNA synthesis or replication inhibitors that are currently used as anticancer therapeutic agents with known side effects.
To read more, please register or connect in the right pannel... |
